Rapid prediction of retina stress and strain patterns in soccer-related ocular injury: integrating finite element analysis with machine learning approach - Shokrollahi Y, Dong P, Kaya M, Suh DW, Gu L.
Soccer-related ocular injuries, especially retinal injuries, have attracted increasing attention. The mechanics of a flying soccer ball have induced abnormally higher retinal stresses and strains, and their correlation with retinal injuries has been charac... (Source: SafetyLit)
Source: SafetyLit - July 29, 2022 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Two In Five Children In India Have No Access To Vitamin A Supplementation
In a new study published in the journal BMJ Global Health, a researcher based in India found that two in five Indian children have never received vitamin A supplementation. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Study: Those Exposed to Asbestos Should Not Take Beta-Carotene
Taking beta-carotene health supplements could increase the risk of lung cancer or death from cardiovascular disease for anyone who is regularly exposed to asbestos, according to a panel of medicine experts.
Based on existing scientific evidence, the U.S. Preventive Services Task Force concluded recently that the potential harms of beta-carotene supplements outweigh any benefits, particularly for those with occupational exposure to asbestos.
The task force, an independent group of medical volunteers, makes recommendations about clinical preventive services. In the same report, it also said vitamin E provided no benefi...
Source: Asbestos and Mesothelioma News - July 25, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos Exposure Clinical Trials/Research/Emerging Treatments Source Type: news
CHMP recommends EU approval of Roche ’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss
Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that driveneovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME)The CHMP recommendation is based on results across four phase III studies: TENAYA and LUCERNE innAMD at year one, and YOSEMITE and RHINE in DME up to two yearsThe totality of the data across all studies innAMD and DME available to date showed that over 60% of people treated withVabysmo were able to extend treatment to every four months, while improving and maintaining visionIf approved,Vabysmo would offer the first new mechanism of action in ...
Source: Roche Investor Update - July 22, 2022 Category: Pharmaceuticals Source Type: news
CHMP recommends EU approval of Roche ’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss
Vabysmo (faricimab) simultaneously targets and inhibits two disease pathways that driveneovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME)The CHMP recommendation is based on results across four phase III studies: TENAYA and LUCERNE innAMD at year one, and YOSEMITE and RHINE in DME up to two yearsThe totality of the data across all studies innAMD and DME available to date showed that over 60% of people treated withVabysmo were able to extend treatment to every four months, while improving and maintaining visionIf approved,Vabysmo would offer the first new mechanism of action in ...
Source: Roche Media News - July 22, 2022 Category: Pharmaceuticals Source Type: news
Age-Related Macular Degeneration: A Marker of CV Disease? Age-Related Macular Degeneration: A Marker of CV Disease?
A specific AMD phenotype was seen to predict presence of vascular, myocardial, or valve disease in patients referred to retinal specialists, leading researchers to ponder its potential in screening.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 22, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Methotrexate Could Reduce the Risk for Retinal Redetachment Methotrexate Could Reduce the Risk for Retinal Redetachment
Intravitreal injections with methotrexate appear to reduce scar formation after retinal reattachment even in patients with proliferative diabetic retinopathy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 20, 2022 Category: Consumer Health News Tags: Ophthalmology News Source Type: news
Abusive head trauma follows witnessed infant shaking - Feldman KW, Melville JD, Johnson KL, Valvano TJ, Piper AC, Lakin KL, Petrak CS.
Abuse is a frequent cause of infant subdural haemorrhages, retinal haemorrhages and neurological dysfunction. Confessed shaking, without impact, is one reported injury cause. However, this remains legally controversial. We evaluated whether witnessed shaki... (Source: SafetyLit)
Source: SafetyLit - July 19, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Retinal haemorrhages in childhood encephalopathies: review of a prospective research programme - Minns RA, Jones PA, Fleck BW, Mulvihill AO.
One important cause of retinal haemorrhages (RHs) in children is abusive head trauma (AHT). Our programme of research was conducted on children admitted to hospital over a seven-year period who had RHs as part of their clinical presentation. This paper sum... (Source: SafetyLit)
Source: SafetyLit - July 19, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Link Between Neovascular Eye Disease, CVD Tracked to Retinal Lesions
(MedPage Today) -- NEW YORK CITY -- Subretinal drusenoid deposits (SDD) had a significant association with underlying cardiovascular disease (CVD), adding a missing link between age-related macular degeneration (AMD) and CVD, a prospective study... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 17, 2022 Category: Cardiology Source Type: news
Gene Therapy Shows Promise for Age-Related Macular Degeneration
(MedPage Today) -- NEW YORK CITY -- A gene therapy for age-related macular degeneration (AMD) led to extended treatment-free intervals and durable improvement in visual acuity and retinal thickening, a preliminary trial showed.
ADVM-022 (ixoberogene... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 15, 2022 Category: Primary Care Source Type: news
New two-year data confirm Roche ’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration
In the TENAYA and LUCERNE studies, more than 60% ofVabysmo patientscould be treated every four months at two years. This represents an increase from 45% at year onePatients treated withVabysmo received a median number of 10 injections over the two years versus 15 injections for those treated withaflibercept, potentially decreasing the number of injectionsNo new safety signals were identified andVabysmo continued to be well tolerated, with afavourable benefit-risk profileBasel, 14 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and LUCERNE studies that reinforce the long-term...
Source: Roche Investor Update - July 14, 2022 Category: Pharmaceuticals Source Type: news
New two-year data confirm Roche ’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration
In the TENAYA and LUCERNE studies, more than 60% ofVabysmo patientscould be treated every four months at two years. This represents an increase from 45% at year onePatients treated withVabysmo received a median number of 10 injections over the two years versus 15 injections for those treated withaflibercept, potentially decreasing the number of injectionsNo new safety signals were identified andVabysmo continued to be well tolerated, with afavourable benefit-risk profileBasel, 14 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and LUCERNE studies that reinforce the long-term...
Source: Roche Media News - July 14, 2022 Category: Pharmaceuticals Source Type: news
NIH researchers decode retinal circuits for circadian rhythm, pupillary light response
Photoreceptor cells in mice drive vision and non-vision functions using distinct circuits in the eye. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 6, 2022 Category: American Health Source Type: news
SERI researchers develop AI tools for screening kidney disease, predicting age using eye photos
Both RetiKid and RetiAge use AI deep learning algorithms to screen for health conditions in retinal images. (Source: mobihealthnews)
Source: mobihealthnews - June 23, 2022 Category: Information Technology Source Type: news
